[1]
“DEVELOPMENTAL ASSESSMENT IN HIGH RISK INFANTS AS COMPARED TO NORMAL INFANTS UPTIL 1 YEAR OF AGE AT TERTIARY CARE CENTRE”, Journal of Pharmaceutical Negative Results, pp. 1839–1848, Jan. 2023, doi: 10.47750/pnr.2023.14.S02.221.